The cancer proteomic landscape and the HUPO Cancer Proteome Project
暂无分享,去创建一个
[1] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[2] E. Fung,et al. Proteomic approaches to tumor marker discovery. , 2002, Archives of pathology & laboratory medicine.
[3] E C Nice,et al. From proteomics to personalized medicine: the road ahead , 2016, Expert review of proteomics.
[4] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[5] R. Bast,et al. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.
[6] D. Chan,et al. The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[7] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[8] Beatriz Carvalho,et al. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening , 2017, Annals of Internal Medicine.
[9] Richard D. LeDuc,et al. High-Throughput Analysis of Intact Human Proteins Using UVPD and HCD on an Orbitrap Mass Spectrometer. , 2017, Journal of proteome research.
[10] B. Kuster,et al. Mass-spectrometry-based draft of the human proteome , 2014, Nature.
[11] Gilbert S Omenn,et al. Advances of the HUPO Human Proteome Project with broad applications for life sciences research , 2017, Expert review of proteomics.
[12] Mehdi Mesri,et al. Linking cancer genome to proteome: NCI's investment into proteogenomics , 2014, Proteomics.
[13] Daniel C. Liebler,et al. Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction* , 2016, Molecular & Cellular Proteomics.
[14] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[15] Michael P. Schroeder,et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.
[16] Lydie Lane,et al. Metrics for the Human Proteome Project 2016: Progress on Identifying and Characterizing the Human Proteome, Including Post-Translational Modifications. , 2016, Journal of proteome research.
[17] Ronald J. Moore,et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.
[18] H. Rodriguez,et al. Collaboration to Accelerate Proteogenomics Cancer Care: The Department of Veterans Affairs, Department of Defense, and the National Cancer Institute's Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network , 2017, Clinical pharmacology and therapeutics.
[19] Mehdi Mesri,et al. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. , 2013, Cancer discovery.
[20] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[21] Suzanne Rose. Huge Data-Sharing Project Launched. , 2016, Cancer discovery.
[22] A. Nesvizhskii,et al. Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. , 2015, Journal of proteome research.
[23] Leroy Hood,et al. Systems Biology and P4 Medicine: Past, Present, and Future , 2013, Rambam Maimonides medical journal.
[24] Gary D Bader,et al. A draft map of the human proteome , 2014, Nature.
[25] Pierre Thibault,et al. The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions* , 2013, Molecular & Cellular Proteomics.
[26] Jiang Lan,et al. Pathology, proteomics and the pathway to personalised medicine , 2018, Expert review of proteomics.
[27] Gary D Bader,et al. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. , 2013, Journal of proteome research.